AGN - Allergan plc

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue15,787,40015,940,70014,570,60012,688,100
Cost of Revenue2,266,0002,145,4001,804,7001,469,200
Gross Profit13,521,40013,795,30012,765,90011,218,900
Operating Expenses
Research Development2,253,4001,990,6002,568,5002,067,200
Selling General and Administrative4,331,2004,542,4004,092,2003,673,300
Non Recurring----
Others----
Total Operating Expenses15,402,90015,875,50014,935,80012,653,400
Operating Income or Loss384,50065,200-365,20034,700
Income from Continuing Operations
Total Other Income/Expenses Net-7,241,400-10,451,600-2,466,800-4,582,200
Earnings Before Interest and Taxes384,50065,200-365,20034,700
Interest Expense-911,200-1,095,600-1,295,600-1,193,300
Income Before Tax-6,856,900-10,386,400-2,832,000-4,547,500
Income Tax Expense-1,770,700-6,670,400-1,897,000-1,605,900
Minority Interest16,90016,0007,800-2,100
Net Income From Continuing Ops-5,086,200-3,716,000-935,000-2,941,600
Non-recurring Events
Discontinued Operations--402,90015,914,5006,861,000
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-5,096,400-4,125,50014,973,4003,915,200
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-5,142,800-4,403,90014,695,0003,683,200